Literature DB >> 22849609

Willingness to accept and pay for implantable tinnitus treatments: a survey.

Navzer D Engineer1, Will M Rosellini, Richard S Tyler.   

Abstract

OBJECTIVES: At present, there is no cure for tinnitus. Neurostimulation techniques have shown great promise, but it is uncertain whether they will gain acceptance because of their invasive nature. We have previously demonstrated that pairing acoustic stimuli with vagus nerve stimulation (VNS) also has potential as a viable tinnitus treatment approach.
METHODS: We conducted a survey on tinnitus sufferers that emphasized questions related to a willingness to pay for the treatment of tinnitus, including VNS. Four hundred thirty-nine individuals responded to an Internet survey modeled after a recent study by Tyler.
RESULTS: The average age was about 47 years. Ninety-four percent reported that they had health insurance. Almost 40% had spent between $500 and $10,000 on tinnitus therapies. Almost three-fourths said that they would be willing to have a device implanted if it reduced tinnitus annoyance by half. About 70% of those with very loud tinnitus would be willing to have a temporary implant, and about 60% would be willing to have a permanent implant even if the device suppressed their tinnitus by only half of its annoyance. Only 10% of patients with SOFT tinnitus would be willing to have a permanent implant if the therapy suppressed their tinnitus by only half of its annoyance.
CONCLUSIONS: We conclude that implanted devices, such as a VNS, will be an acceptable form of tinnitus treatment for many who suffer from tinnitus. The results of this survey indicate that VNS tone pairing would be an acceptable therapeutic solution for individuals with moderate to severe tinnitus and should be developed for the market.
© 2012 International Neuromodulation Society.

Entities:  

Mesh:

Year:  2012        PMID: 22849609     DOI: 10.1111/j.1525-1403.2012.00487.x

Source DB:  PubMed          Journal:  Neuromodulation        ISSN: 1094-7159


  5 in total

Review 1.  [Newest therapeutic approaches for chronic tinnitus].

Authors:  G Hesse
Journal:  HNO       Date:  2015-04       Impact factor: 1.284

Review 2.  Evidence and evidence gaps in tinnitus therapy.

Authors:  Gerhard Hesse
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2016-12-15

3.  Impact of Pharmacogenomic Information on Values of Care and Quality of Life Associated with Codeine and Tramadol-Related Adverse Drug Events.

Authors:  Ye Zhu; Guilherme S Lopes; Suzette J Bielinski; Bijan J Borah; Nicholas B Larson; Ann M Moyer; Janet E Olson; Liewei Wang; Richard Weinshilboum; Jennifer L St Sauver
Journal:  Mayo Clin Proc Innov Qual Outcomes       Date:  2021-01-13

4.  Electrical stimulation of the cochlea for treatment of chronic disabling tinnitus: an open-label trial towards the development of an implantable device.

Authors:  John P Marinelli; C Lane Anzalone; Christoph M Prummer; Gayla L Poling; Jeffrey P Staab; Nicole M Tombers; Christine M Lohse; Matthew L Carlson
Journal:  J Transl Med       Date:  2022-01-29       Impact factor: 5.531

5.  The Utility of Economic Measures to Quantify the Burden of Tinnitus in Affected Individuals: A Scoping Review.

Authors:  Elza Daoud; Charlotte Caimino; Michael A Akeroyd; Arnaud J Noreña; David M Baguley
Journal:  Pharmacoecon Open       Date:  2021-07-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.